BSE Code NSE Code ISIN Scrip Name NSE Intraday Margin % BSE
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Index Outlook June 2021
Index Outlook JUNE 2021 June 28, 2021 Nifty Sectoral Weights* Weight Weight Change Earnings stage smart upgrade, further upside seen… Sectors (Nov 2020) (Jun 2021) (bps) Indian markets have shown resilience in the recent past and scaled new BFSI 37.8% 37.4% -42 highs amid encouraging corporate earnings in Q4FY21 led by the upswing IT 16.4% 16.3% -9 in key commodities prices and strong underlying demand prospects. GST Oil and Gas 14.1% 12.6% -153 collection at ~| 1.02 lakh crore for May 2021 (eighth consecutive month of FMCG 8.5% 8.2% -34 >| 1 lakh figure) is testimony to robust domestic macroeconomics. Going Capital Goods 2.3% 2.7% 37 forward, with peak of the Covid resurgence behind us, increasing pace of Auto 5.3% 5.3% 1 vaccination domestically and calibrated state specific unlocking under way, Metals and Mining 2.3% 3.5% 117 we expect economic activity to bounce back sharply in 9MFY22E. Our view Power 1.7% 1.6% -8 is further reinforced by the step up capex by the government, which will Telecom 2.1% 1.9% -21 Report Special create multiplier effect on the economy. We expect the present broad-based Pharma 3.5% 3.5% -1 up move in markets to continue, with small cap and midcaps leading the Others 5.9% 7.1% 123 gains. We continue to like IT & pharma space as structural plays in the market. Total 100% 100% Exhibit 1: Nifty and Sensex targets *Index weights are dynamic in nature Revised Sensex & Nifty Target resultant to market price movement & Earnings Estimates FY19 FY20 FY21 FY22E FY23E susceptible to change going forward Nifty EPS (₹/share) -
Download Full Report
CONTENTS 02 Unstoppable Corporate overview We have been persistent 02 Unstoppable in our aim to establishing 04 Chairman’s Message and maintaining market leadership to be able to achieve 06 Vice Chairman’s Message unprecedented growth for our 08 Board of Directors stakeholders. 10 Management Board 12 Key Performance Highlights 14 14 Integrated Report Integrated Report 28 Management Discussion & Analysis Apollo Tyres’ contribution 51 Sustainability Snapshot to social and economic development is critical to create and sustain an enabling environment for investment. This has enabled the Company’s positioning as a credible Statutory Reports stakeholder partner. 84 Board’s Report 95 Annual Report on CSR 28 102 Business Responsibility Report Management 126 Corporate Governance Report Discussion & Analysis Financial Statements 161 Standalone Financial Statements 223 Consolidated Financial Statements UNSTOPPABLE Since inception, we have worked towards establishing ourselves as a leading player in the sale and manufacture of tyres. We have been persistent in our aim to establishing and maintaining market leadership and be able to achieve unprecedented growth for our stakeholders. In FY2018-19 (FY2019), we continued to focus We are unstoppable in establishing our on our key revenue generating regions APMEA leadership across multiple segments. (Asia Pacific, Middle East and Africa, including Our consistently advancing product range coupled India) and Europe. We expanded our presence in with product innovations are enabling us to achieve Americas by added new territories and increasing the same. our value proposition. The APMEA operation continued its focus on consolidating its leadership We are unstoppable in working towards achieving and enhancing share in India through the cutting edge manufacturing capabilities and introduction of best in class and technologically world-class R&D. -
Inner 20 Ethical Fund Low
Tata Ethical Fund (An open ended equity scheme following Shariah principles) As on 30th June 2020 PORTFOLIO No. of Market Value % of No. of Market Value % of INVESTMENT STYLE Company name Company name An equity scheme which invests primarily in equities of Shares Rs. Lakhs Assets Shares Rs. Lakhs Assets Shariah compliant companies and other instrument if Equity & Equity Related Total 49401.57 90.21 Oil allowed under Shariah principles. Auto Oil & Natural Gas Co. 925000 752.49 1.37 INVESTMENT OBJECTIVE Hero Motocorp Ltd. 31300 797.20 1.46 Pesticides To provide medium to long- term capital gains by investing Auto Ancillaries Rallis India Ltd. 502000 1366.95 2.50 in Shariah compliant equity and equity related instruments Wabco India Ltd. 15800 1087.06 1.99 Petroleum Products of well-researched value and growth - oriented companies. Sundram Fasteners Ltd. 267000 999.38 1.83 Bharat Petroleum Corporation Ltd. 435000 1626.90 2.97 Tata Ethical Fund aims to generate medium to long term Amara Raja Batteries Ltd. 116849 759.99 1.39 Castrol India Ltd. 505000 634.79 1.16 capital growth by investing in equity and equity related Cement Pharmaceuticals instruments of shariah compliant companies. Shree Cement Ltd. 3800 875.94 1.60 Alkem Laboratories Ltd. 83000 1965.69 3.59 DATE OF ALLOTMENT Commercial Services Ipca Laboratories Ltd. 93750 1569.75 2.87 May 24,1996 3M India Ltd. 4500 845.79 1.54 Lupin Ltd. 145000 1322.11 2.41 Consumer Durables Software FUND MANAGER Titan Company Ltd. 113000 1073.33 1.96 Tata Consultancy Services Ltd. -
Annual Report 2017-18
Godrej Industries Ltd. www.godrejindustries.com ANNUAL REPORT 2017-18 Contents Board of Directors 02 Corporate Information 04 Chairman’s Statement 06 Financial Highlights 11 Notice & Explanatory Statement 13 Board's Report 27 Report on Corporate Governance 93 Auditor’s Report (Consolidated) 113 Consolidated Accounts 120 Auditor's Report (Standalone) 217 Standalone Accounts 224 Statement Pursuant to Section 129 283 1 BOARD OF DIRECTORS A. B. Godrej Chairman N. B. Godrej Managing Director T. A. Dubash Executive Director & Chief Brand Officer J. N. Godrej V. M. Crishna N. S. Nabar Executive Director & President (Chemicals) K. K. Dastur S. A. Ahmadullah A. B. Choudhury A. D. Cooper K. N. Petigara K. M. Elavia Corporate Information AUDITORS : BSR & Co. LLP, Chartered Accountants BOARD COMMITTEES Audit Committee : K. K. Dastur (Chairman) S. A. Ahmadullah K. N. Petigara A. B. Choudhury Nomination & : S. A. Ahmadullah (Chairman) Compensation Committee A. B. Choudhury K. N. Petigara Stakeholders Relationship/ : A. B. Godrej (Chairman) Shareholders Committee N. B. Godrej T. A. Dubash N. S. Nabar Corporate Social : N. B. Godrej (Chairman) Responsibility Committee: T. A. Dubash K. N. Petigara A. B. Choudhury Risk Management Committee : N. B. Godrej (Chairman) T. A. Dubash N. S. Nabar Management Committee : A. B. Godrej (Chairman) N. B. Godrej A. D. Cooper T. A. Dubash N. S. Nabar CHIEF FINANCIAL OFFICER : Clement Pinto COMPANY SECRETARY : Nilufer Shekhawat REGISTERED OFFICE : Godrej One, Pirojshanagar, Eastern Express Highway, Vikhroli (East), Mumbai 400 079. Phone: 022-2518 8010, 2518 8020, 2518 8030 Fax: 022-2518 8066 website: www.godrejindustries.com CIN No.: L24241MH1988PLC097781 4 REGISTRARS & TRANSFER AGENT : Computech Sharecap Ltd. -
Big Power Trade - Futuros National Stock Exchange of India (NSE)
BiG Power Trade - Futuros National Stock Exchange of India (NSE) País / Região Bolsa Produto Horário Futuros (Moeda, National Stock Exchange of India (NSE) Segunda-feira - Sexta-feira: Acções, Índices de 9:15-15:30 IST* Índia www.nseindia.com acções) IB Simbolo Instrumento Simbolo Moeda ACC ACC LIMITED ACC INR ADANIPOWE ADANI POWER LIMITED ADANIPOWER INR AJANTPHAR AJANTA PHARMA LTD AJANTPHARM INR ALBK ALLAHABAD BANK ALBK INR AMARAJABA AMARA RAJA BATTERIES LTD AMARAJABAT INR AMBUJACEM AMBUJA CEMENTS LIMITED AMBUJACEM INR ANDHRABAN ANDHRA BANK ANDHRABANK INR APOLLOHOS APOLLO HOSPITALS ENTERPRISE APOLLOHOSP INR APOLLOTYR APOLLO TYRES LIMITED APOLLOTYRE INR ARVIND ARVIND LTD ARVIND INR ASHOKLEY ASHOK LEYLAND LIMITED ASHOKLEY INR ASIANPAIN ASIAN PAINTS LTD ASIANPAINT INR AUROPHARM AUROBINDO PHARMA LTD AUROPHARMA INR AXISBANK AXIS BANK LTD AXISBANK INR BAJAJ-AUT BAJAJ AUTO LIMITED BAJAJ-AUTO INR BAJAJFINS BAJAJ FINSERV LTD BAJAJFINSV INR BAJFINANC BAJAJ FINANCE LTD BAJFINANCE INR BALKRISIN BALKRISHNA INDUSTRIES LTD BALKRISIND INR BALRAMCHI BALRAMPUR CHINI MILLS LTD BALRAMCHIN INR BANKBAROD BANK OF BARODA BANKBARODA INR BANKINDIA BANK OF INDIA BANKINDIA INR BANKNIFTY Nifty Bank BANKNIFTY INR BATAINDIA BATA INDIA LTD BATAINDIA INR BEL BHARAT ELECTRONICS LTD BEL INR BEML BEML LIMITED BEML INR BERGEPAIN BERGER PAINTS INDIA LTD BERGEPAINT INR BHARATFIN BHARAT FINANCIAL INCLUSION L BHARATFIN INR BHARATFOR BHARAT FORGE LIMITED BHARATFORG INR BHARTIART BHARTI AIRTEL LIMITED BHARTIARTL INR BHEL BHARAT HEAVY ELECTRICALS BHEL INR BIOCON BIOCON LTD BIOCON -
SANJEEVAK 1586083 01/08/2007 MANOJ ANANT JOSHI Trading As ;AKSHAY PHARMA REMEDIES KAVRANA HOUSE, OPP
Trade Marks Journal No: 1836 , 12/02/2018 Class 5 SANJEEVAK 1586083 01/08/2007 MANOJ ANANT JOSHI trading as ;AKSHAY PHARMA REMEDIES KAVRANA HOUSE, OPP. COTTON GREEN RLY. STN. MUMBAI-400033. MANUFACTURE & MERCHANT INDIAN NATIONAL Used Since :31/01/2001 MUMBAI MEDICINAL PREPARATIONS. 537 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 SEPTIGARD 1741718 08/10/2008 INDERJIT SINGH trading as ;INDERJIT SINGH B-104 , SWASTHYA SINGH , NEW DELHI -92 MERCHANTS & MANUFACTUERERS Address for service in India/Agents address: MAHTTA & CO. 43 - B/3, MAHTTA HOUSE,UDHAM SINGH NAGAR, LUDHIANA - 141 001, (PUNJAB). Proposed to be Used DELHI MEDICINAL & PHARMACEUTICAL PREPARATIONS. 538 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 FAIR & BEAUTY 1803779 08/04/2009 GALPHA LABORATORIES LIMITED 221, Kanakia Zillion, E Wing Bandra Kurla Complex Annex LBS Marg & CST Road Junction Kurla West MUMBAI 400070 MANUFACTURERS AND MERCHANTS INDIAN NATIONAL Used Since :15/11/2007 MUMBAI PHARMACEUTICAL AND MEDICINAL PREPARATIONS AND SUBSTANCES 539 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 O-BAMA 1815900 08/05/2009 KREMOINT PHARMA PVT. LTD. 151/5, SHRI KRISHNA DARSHAN, GARODIA NAGAR, GHATKOPAR (E), BOMBAY-400 077. MANUFACTURERS AND MERCHANTS. A CORPORATE ENTITY INCORPORATED IN INDIA UNDER THE COMPANIES ACT 1956. Address for service in India/Attorney address: KRISLAW CONSULTANTS BUILDING NO.4, C/104, SHANKESHWAR PALMS, BEHIND MODEL SCHOOL, KUMBHARKHANPADA, SUBHASH ROAD, DOMBIVILI(W) 421202 Used Since :02/05/2009 MUMBAI PHARMACETICAL AND MEDICINAL PREPARATIONS. 540 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 AYUSHAKTI D-VYRO 1815928 08/05/2009 SMITA NARAM BUNGALOW NO.31, NEXT TO M. -
Nominee List
NOMINEE LIST Best financial reporting (large cap) Cipla Hindalco Industries Hindustan Unilever Infosys Kotak Mahindra Bank Mahindra & Mahindra Piramal Enterprises Tata Steel Vedanta Best financial reporting (small to mid-cap) CEAT Everest Industries Hikal Hindustan Foods IIFL Holdings KEC International Minda Industries Raymond The Phoenix Mills Zensar Technologies Best investor meetings (large cap) Bharti Airtel Hindustan Unilever Infosys Lupin Mahindra & Mahindra Piramal Enterprises Best investor meetings (mid-cap) Balkrishna Industries IIFL Holdings Mindtree RPG Group Sterlite Technologies The Phoenix Mills NOMINEE LIST Best investor meetings (small cap) Amber Enterprises India Equitas Holdings Greenlam Industries Music Broadcast Navin Fluorine International NOCIL Raymond Zensar Technologies Best investor relations officer (large cap) Bharti Airtel Komal Sharan Bharti Airtel Aparna Vyas Garg Bharti Infratel Surabhi Chandna Cipla Naveen Bansal HDFC Conrad D'Souza Hindustan Unilever Suman Hegde Infosys Sandeep Mahindroo Kotak Mahindra Bank Nimesh Kampani Lupin Arvind Bothra Best investor relations officer (small to mid-cap) CEAT Pulkit Bhandari Jindal Steel & Power Nishant Baranwal Motilal Oswal Financial Services Rakesh Shinde PNB Housing Finance Deepika Gupta Padhi Raymond J Mukund RPG Group Pulkit Bhandari Schneider Electric Infrastructure Vineet Jain The Phoenix Mills Varun Parwal NOMINEE LIST Best investor relations team (large cap) Bharti Airtel Cipla Hindustan Unilever Infosys Kotak Mahindra Bank Larsen & Toubro Infotech Power -
Welspun Gujarat Crosses Coveted $ 1 Billion Mark
BUSINESS UPDATE Welspun Corp Limited - ‘1 mn Ton’ Pipe Order Book - Significant contribution by International Operations - Well poised to get new prestigious orders Sales up by 12% in FY 12 and 24% in Q4 FY 12 Operating EBITDA sustained despite difficult market conditions Mumbai, May 29 2012: Welspun Corp Ltd. (WCL) the flagship Company of the $3.5 billion Welspun Group today announced its financial results for the FY2012 & 4th Quarter FY 2012. Consolidated Financial Summary of Q4 FY12 and FY 2012 (Figures in Rs. Million) Particulars FY 2012 FY 2011 Change % Q4 FY12 Q4 FY11 Change % Sales 89,766 80,221 12% 26,998 21,744 24% Other Income 2,676 1,139 135% 1,061 410 159% EBITDA 11,246 13,784 -18% 3,673 2,852 29% Interest 3,999 2,240 79% 1,157 755 53% Depreciation 3,515 2,439 44% 918 632 45% PAT 2,385 6,330 -62% 1,186 1,181 0% Cash PAT 6,192 9,700 -36% 2,360 2,218 6% EPS (Rs./Share) 9.71 28.66 -66% 4.53 5.41 -16% Reported EBITDA Margin (%) 12.5% 16.22% 13.60% 13.12% PAT Margin (%) 2.66% 7.89% 4.39% 5.43% Operational Numbers after accounting for exceptional items*: Particulars FY 12 Q4 FY 12 Operational EBITDA 10,467 1,551 PAT 3,685 469 CASH PAT 7,492 1,644 * FY12 operational performance was impacted by foreign exchange provisions of Rs ,1244 million and provisions made towards amicable settlement with a customer of Rs 649 million. -
Hy Sun Missed the Pharma Rally: the Answer Is Hidden in a Bet Many Failed — Speciality Drugs - the Economic Times
12/3/2020 Sun Pharma: Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs - The Economic Times Home ETPrime Markets News Industry RISE Politics Wealth MF Tech Jobs Opinion NRI Panache ET NOW More Aayush English Edition | E-Paper Tech Consumer Markets Corporate Governance Telecom + OTT Auto + Aviation Pharma Fintech + BFSI Economy Infra Environment Energy Business News › Prime › Pharma › Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs Getty Images MARKETS hy Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs Dilip Shanghvi, founder and managing director, Sun Pharmaceuticals Synopsis Sun Pharma is the only Indian company to have made some inroads into speciality drugs. What worries investors is high investments and uncertainties over ramp up in revenue. The stock can still see upside because of its current valuations, strong India business, and any positive surprises in US generic business. But it is crucial that its speciality bet pays off. BACK TO TOP https://economictimes.indiatimes.com/prime/pharma-and-healthcare/why-sun-missed-the-pharma-rally-the-answer-is-hidden-in-a-bet-many-failed-spe… 1/11 12/3/2020 Sun Pharma: Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs - The Economic Times Home ETPrime Markets NeCwasllI nitd uas trbyleRssISiEngP oilniti cdsisWgeuailthse fMoFr tTheceh InJodbisanOpinion NRI Panache ET NOW More pharmaceutical industry. The stocks of pharma companies have been on a tear since the beginning of the Covid-19 crisis. -
Large Diamater Welded Pipe India Countervailing Duty Final Determination
C-533-882 Investigation Public Document E&C/VIII: STL DATE: November 5, 2018 MEMORANDUM TO: Gary Taverman Deputy Assistant Secretary for Antidumping and Countervailing Duty Operations, performing the non-exclusive functions and duties of the Assistant Secretary for Enforcement and Compliance FROM: James Maeder Associate Deputy Assistant Secretary for Antidumping and Countervailing Duty Operations performing the duties of Deputy Assistant Secretary for Antidumping and Countervailing Duty Operations SUBJECT: Issues and Decision Memorandum for the Final Affirmative Determination of the Countervailing Duty Investigation of Large Diameter Welded Pipe from India I. SUMMARY The Department of Commerce (Commerce) determines that countervailable subsidies are being provided to producers and exporters of large diameter welded pipe from India, as provided in section 705 of the Tariff Act of 1930, as amended (the Act). Below is the complete list of issues in this investigation for which we received comments from interested parties. Issues Comment 1: Whether Commerce Properly Applied Adverse Facts Available (AFA) in the Preliminary Determination. Comment 2: Whether Commerce Should Continue to Find the AAP, DDP, EPCG, and MEIS Programs Countervailable II. BACKGROUND A. Case History On June 29, 2018, Commerce published its Preliminary Determination for this investigation.1 The selected mandatory respondents in this investigation are Bhushan Steel (Bhushan) and Welspun Trading Limited (Welspun). In the Preliminary Determination, we aligned the final countervailing duty (CVD) determination with the final determination in the companion antidumping duty (AD) investigation, in accordance with section 705(a)(1) of the Act and 19 CFR 351.210(b)(4). As noted in the Preliminary Determination, Bhushan and Welspun did not respond to Commerce’s initial questionnaire. -
An Analysis of Corporate Social Responsibility Initiatives of Selected Manufacturing Companies in Karnataka
IOSR Journal of Business and Management (IOSR-JBM) e-ISSN: 2278-487X, p-ISSN: 2319-7668 (April, 2017) PP 23-28 www.iosrjournals.org An Analysis of Corporate Social Responsibility Initiatives of Selected Manufacturing Companies in Karnataka Ramaprakasha. N1 & Dr.Y.Rajaram2 1 Faculty, Maharaja’s College, University of Mysore, Mysuru. 2 Professors, Ramaiah Institute of Management Studies, Bengaluru. Abstract: The enactment of The New Companies Act 2013 is a major milestone in corporate governance, which has resulted in a paradigm shift in business operations across India. Almost all major companies are practicing corporate social responsibility (CSR) and are contributing towards the development of society and environment within which they operate. In the present paper an attempt has been made to throw light on the prominent corporate social responsibility initiatives of the selected manufacturing companies in Karnataka, to determine the trend and orientation of corporate social responsibility and to examine whether there is significant difference in the orientation and implementation of corporate social responsibility initiatives among the selected manufacturing companies in Karnataka. Key words: Corporate social responsibility, Karnataka, Manufacturing companies. I. Introduction Corporate Social Responsibility (CSR) has developed as an important area of management after the enactment of The New Companies Act-2013. CSR is defined as the obligations of a company towards the society and environment within which it operates. CSR was previously a voluntary exercise which were practiced only by a few reputed companies but The New Companies Act which came into force from 01 April, 2014 in India made corporate social responsibility mandatory for companies operating in India having a net profit of Rs 5 crores or above or a net worth of Rs 500 crores or above or a total turnover of Rs 1000 crores or above during any financial year. -
IN the BUSINESS of PROGRESS CONTENTS Apollo Tyres in Brief
Annual Report 2019-20 IN THE BUSINESS OF PROGRESS CONTENTS Apollo Tyres in brief 01-03 Apollo Tyres is one of the most trusted Corporate factsheet names in the manufacture and sale of tyres. The Company was founded in 1972 and is 04-13 headquartered in Gurugram, Haryana (India). Leadership and governance 06 Chairman’s message 08 Vice-Chairman’s message 10 Board of Directors Catering to all tyre segments 12 Management Team TRUCK AND BUS LIGHT TRUCK 14-77 Performance and progress 16 Key performance indicators 18 Know our capitals 20 Business model 22 Capital-wise information 36 Progress amidst volatility 38 Progress that is sustainable 40 Progress through people centricity 42 Value created for the stakeholders PASSENGER VEHICLES TWO-WHEELER 78-93 Management Discussion & Analysis 94-170 Statutory Reports 94 Board’s Report 107 Annual Report on CSR 113 Business Responsibility Report 138 Corporate Governance Report OFF-HIGHWAY 171-305 Financial Statements 171 Standalone 233 Consolidated Apollo Tyres’ success as a leading tyre such as: geo-political relations, economic manufacturer is inextricably linked with the growth, industry cyclicality, environmental progress of the people, the businesses we issues, technological innovation, safety and partner and the planet at large. We have consumer attitudes. Our FY20 performance is always persevered to exceed expectations, a reflection of the resulting uncertainties. It set new benchmarks and in some cases, is also a testament to our foundational values shape the future of the industry. and intrinsic strengths that have helped us navigate through these uncertainties. Our marquee brands, Apollo and Vredestein, enjoy premium positions in the commercial As we step into a new decade, replete with and passenger vehicle tyre segments in unexplored opportunities, we are keen on India and Europe, respectively.